Paper29316653
Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke.
Faggi L and 13 others. Int J Mol Sci, 2018. Cited by 31 papers, by iCite.
Cite this record
ConductScience Library. Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke. Papers, record 29316653. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29316653
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synergistic Association of Valproate and Resveratrol Reduces Brain Injury in Ischemic Stroke.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Histone Deacetylase Inhibitors | Major topic |
| Neuroprotective Agents | Major topic |
| Stilbenes | Major topic |
| Stroke | Major topic |
| Valproic Acid | Major topic |
| Acetylation | |
| Animals | |
| Bcl-2-Like Protein 11 | |
| Disease Models, Animal | |
| Drug Synergism | |
| Histones | |
| Male | |
| Mice | |
| Mice, Inbred C57BL | |
| Neurons | |
| Promoter Regions, Genetic | |
| Protein Binding | |
| Resveratrol | |
| Transcription Factor RelA |
Source PubMed
References56
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16946032 | Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. | Mol Pharmacol | 2006 | https://conductscience.org/library/papers/16946032 | PubMed |
| 2 | 17882162 | In vivo and in vitro characterization of a novel neuroprotective strategy for stroke: ischemic postconditioning. | J Cereb Blood Flow Metab | 2008 | https://conductscience.org/library/papers/17882162 | PubMed |
| 3 | 25628792 | Post-insult valproate treatment potentially improved functional recovery in patients with acute middle cerebral artery infarction. | Am J Transl Res | 2014 | https://conductscience.org/library/papers/25628792 | PubMed |
| 4 | 18234895 | Targeted disruption of Na+/Ca2+ exchanger 3 (NCX3) gene leads to a worsening of ischemic brain damage. | J Neurosci | 2008 | https://conductscience.org/library/papers/18234895 | PubMed |
| 5 | 11345520 | Cyclic AMP response element binding protein (CREB) and CREB binding protein (CBP) in global cerebral ischemia. | J Mol Neurosci | 2001 | https://conductscience.org/library/papers/11345520 | PubMed |
| 6 | 15901671 | Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. | FASEB J | 2005 | https://conductscience.org/library/papers/15901671 | PubMed |
| 7 | 23929628 | Advances and challenges in treatment and prevention of ischemic stroke. | Ann Neurol | 2013 | https://conductscience.org/library/papers/23929628 | PubMed |
| 8 | 17227229 | NF-kappa B as a therapeutic target in neurodegenerative diseases. | Expert Opin Ther Targets | 2007 | https://conductscience.org/library/papers/17227229 | PubMed |
| 9 | 16338217 | Dual effects of histone deacetylase inhibition by trichostatin A on endothelial nitric oxide synthase expression in endothelial cells. | Biochem Biophys Res Commun | 2006 | https://conductscience.org/library/papers/16338217 | PubMed |
| 10 | 12269861 | Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. | CNS Drugs | 2002 | https://conductscience.org/library/papers/12269861 | PubMed |
| 11 | 21632213 | Are post intracerebral hemorrhage seizures prevented by anti-epileptic treatment? | Epilepsy Res | 2011 | https://conductscience.org/library/papers/21632213 | PubMed |
| 12 | 21368872 | The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury. | Cell Death Dis | 2010 | https://conductscience.org/library/papers/21368872 | PubMed |
| 13 | 10734189 | Transcriptional repression by the insulator protein CTCF involves histone deacetylases. | Nucleic Acids Res | 2000 | https://conductscience.org/library/papers/10734189 | PubMed |
| 14 | 17167080 | Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia. | J Neurosci | 2006 | https://conductscience.org/library/papers/17167080 | PubMed |
| 15 | 10463134 | Attenuation by acetyl-L-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion. | Int J Tissue React | 1999 | https://conductscience.org/library/papers/10463134 | PubMed |
| 16 | 24748101 | Histone acetylation and CREB binding protein are required for neuronal resistance against ischemic injury. | PLoS One | 2014 | https://conductscience.org/library/papers/24748101 | PubMed |
| 17 | 18066503 | Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities. | Mol Neurobiol | 2008 | https://conductscience.org/library/papers/18066503 | PubMed |
| 18 | 15717006 | Neuroprotection for ischemic stroke: two decades of success and failure. | NeuroRx | 2004 | https://conductscience.org/library/papers/15717006 | PubMed |
| 19 | 16854410 | Distinct roles of diverse nuclear factor-kappaB complexes in neuropathological mechanisms. | Eur J Pharmacol | 2006 | https://conductscience.org/library/papers/16854410 | PubMed |
| 20 | 17371805 | Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. | J Pharmacol Exp Ther | 2007 | https://conductscience.org/library/papers/17371805 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42654293 | Resveratrol and Curcumin in Stroke Therapy: From Experimental Evidence to Clinical Perspectives. | Nutrients | 2026 | https://conductscience.org/library/papers/42654293 | PubMed |
| 41907041 | Resveratrol modulates FABP5 to reduce neuronal apoptosis following ischemic stroke. | Open Life Sci | 2026 | https://conductscience.org/library/papers/41907041 | PubMed |
| 41249333 | The study of promoting the rational use of sodium valproate in the intensive care unit. | Sci Rep | 2025 | https://conductscience.org/library/papers/41249333 | PubMed |
| 40760225 | Neuroprotective effects of resveratrol and sodium valproate in penicillin-induced epilepsy model. | Metab Brain Dis | 2025 | https://conductscience.org/library/papers/40760225 | PubMed |
| 40341167 | Role of histone deacetylases and sirtuins in the ischaemic stroke: a systematic review and meta-analysis of animal studies. | Stroke Vasc Neurol | 2026 | https://conductscience.org/library/papers/40341167 | PubMed |
| 40305347 | Histone Modifications: Potential Therapeutic Targets for Diabetic Retinopathy. | Biomolecules | 2025 | https://conductscience.org/library/papers/40305347 | PubMed |
| 39884996 | Neuroprotective effects of phytochemicals through autophagy modulation in ischemic stroke. | Inflammopharmacology | 2025 | https://conductscience.org/library/papers/39884996 | PubMed |
| 39082038 | A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke. | Heliyon | 2024 | https://conductscience.org/library/papers/39082038 | PubMed |
| 37802493 | Effect and mechanisms of resveratrol in animal models of ischemic stroke: A systematic review and Bayesian meta-analysis. | J Cereb Blood Flow Metab | 2023 | https://conductscience.org/library/papers/37802493 | PubMed |
| 36904106 | Polyphenols Mediate Neuroprotection in Cerebral Ischemic Stroke-An Update. | Nutrients | 2023 | https://conductscience.org/library/papers/36904106 | PubMed |
| 36339574 | Synergistic association of resveratrol and histone deacetylase inhibitors as treatment in amyotrophic lateral sclerosis. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36339574 | PubMed |
| 36232980 | Resveratrol Mitigates Oxygen and Glucose Deprivation-Induced Inflammation, NLRP3 Inflammasome, and Oxidative Stress in 3D Neuronal Culture. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36232980 | PubMed |
| 35885011 | Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery in Neurodegenerative Disorders. | Biomedicines | 2022 | https://conductscience.org/library/papers/35885011 | PubMed |
| 35625674 | Experimental Models for Testing the Efficacy of Pharmacological Treatments for Neonatal Hypoxic-Ischemic Encephalopathy. | Biomedicines | 2022 | https://conductscience.org/library/papers/35625674 | PubMed |
| 35347532 | The Bridge Between Ischemic Stroke and Gut Microbes: Short-Chain Fatty Acids. | Cell Mol Neurobiol | 2023 | https://conductscience.org/library/papers/35347532 | PubMed |
| 35162978 | Beneficial and Sexually Dimorphic Response to Combined HDAC Inhibitor Valproate and AMPK/SIRT1 Pathway Activator Resveratrol in the Treatment of ALS Mice. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35162978 | PubMed |
| 34987407 | Resveratrol has an Overall Neuroprotective Role in Ischemic Stroke: A Meta-Analysis in Rodents. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34987407 | PubMed |
| 34681788 | Hypoxia Tolerant Species: The Wisdom of Nature Translated into Targets for Stroke Therapy. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34681788 | PubMed |
| 34365594 | Therapeutic Effects of Resveratrol on Ischemia-Reperfusion Injury in the Nervous System. | Neurochem Res | 2021 | https://conductscience.org/library/papers/34365594 | PubMed |
| 34216182 | HDACi protects against vascular cognitive impairment from CCH injury via induction of BDNF-related AMPA receptor activation. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/34216182 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BCL2L11 | 10018 | PubTator's text mining | https://conductscience.org/library/genes/10018 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| PRKAA2 | 5563 | PubTator's text mining | https://conductscience.org/library/genes/5563 | NCBI Gene |
| RELA | 5970 | PubTator's text mining | https://conductscience.org/library/genes/5970 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29316653
GET https://conductscience.org/api/papers/v1/29316653/references?page=2